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Abstract The presence of tyrosine-phospborylated proteins was 
studied in cultured rat pancreatic islets. Immunoblotting per- 
formed with total extracts of islets cultured in the presence of 1.8 
or 5.6 mM glucose revealed at least three distinct tyrosine- 
phosphorylated bands (25 kDa, 95 kDa and 165-185 kDa). After 
12 h incubation in medium containing 1.8 mM glucose, a pulse 
exposition to 11 or 22 mM glucose or to I0 -7 M insulin led to a 
substantial increase in the phosphorylation of all three bands, with 
no appearance of novel bands. Immunoprecipitation with specific 
antibodies demonstrated that the signal detected at 95 kDa corre- 
sponds to the ~ subunit of the i ~  receptor (IR) while the band 
at 165-185 kDa corresponds to the early substrates of the insulin 
receptor, IRSd and IRS-2. Immunoprecipitation with IRS-I or 
IRS-2 antisera detected their association with the lipid metaboliz- 
ing enzyme pbosphatidylinositol 3-kinase (PI 3-kinase). Thus, 
this is the first demonstration that elements involved in the insulin- 
signalling pathway of traditional target tissues are also present 
in pancreatic islets and are potentially involved in auto- and 
paracrine-signalling in this organ. 
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I. Introduction 
Protein tyrosine phosphorylation is an important mechanism 
of intracellular signalling, Insulin action in target tissues is 
initiated by binding of  the ligand to its receptor (IR), promoting 
the autophosphorylation f its fl subunit and subsequently trig- 
gering a cascade of intracellular signalling [1]. Two early sub- 
strates of the activated IR are the 165,000~185,000 M,. IRS-I 
and IRS-2 [1,2]. Once phosphorylated, IRS-1/2 bind to and 
activate a series of SH2 motif-containing substrates, including 
proteins of the src family, phosphotyrosine phosphatases, uch 
as SHPTP2, and the lipid-modifying enzyme PI 3-kinase [1,3]. 
Studies attempting to clarify early events in the insulin-sig- 
nalling pathway were performed mostly in liver, muscle and 
adipose tissue and, although most of the metabolic actions of 
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insulin are exerted in those tissues, it is widely accepted that 
insulin also possesses auto- and paracrine actions in the cells 
of the pancreatic islets. However, the mechanisms involved in 
insulin-signalling in the islets of Langerhans are not known. 
Recent evidences uggest hat the inhibition of tyrosine ki- 
nase activity in cultured pancreatic islets leads to a considerable 
increase in insulin secretion [4]. To address the issue of the 
involvement of tyrosine phosphorylation-mediated events in 
the control of islet function and in insulin-signalling in the islets 
of Langerhans, primary cultures of rat pancreatic islets were 
examined for the presence of tyrosine-phosphorylated proteins 
under basal and stimulated conditions. 
2. Materials and methods 
2 1. Chemicals and antibodies 
The reagents and apparatus for SDS-PAGE and immunoblotting 
were from Bio-Rad (Richmond, CA). Tris, PMSF, EDTA, aprotinin 
and DTT were from Sigma (St Louis, MO). Sodium amobarbital nd 
insulin were from Eli Lilly (Indiana, IN). [LzsI]Protein A was from 
Amersham (Buckinghamshire, UK) and Protein A Sepharose 6 MB 
was from Pharmacia (Uppsala, Sweden). Nitrocellulose (BA85, 0.2 
ram) was from Schleicher & Schuell (Keene, NH). Monoclonal antibod- 
ies antiphosphotyrosine and anti-p85 (PI 3-kinase) were from UB1 
(Lake Placid, NY). Antisera anti-IRS-1, IRS-2 and IR were raised in 
rabbits as previously described [2,5]. 
2.2. B~!/li, rs 
Buffer A contained 100 mM Tris, 1% SDS, 50 mM Hepes (pH 7.4), 
10(1 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM 
EDTA and 10 mM sodium vanadate. Buffer B was similar to buffer A 
except hat 1% Triton X-100 replaced 1% SDS and 2 mM PMSF and 
[). 1 mg/ml aprotinin were added. Buffer C contained 100 mM Tris, 10 
mM sodium vanadate, 10 mM EDTA and l% Triton X-100. 
2.3..4 n#md~s 
MaDe Wistar rats were bred at the animal facilities of the State 
University of Campinas. The animals used in the experiments were 
151) 180 g and were given standard rodent chow and water ad libitum. 
Food was withdrawn 12 14 h before islet isolation. 
2 4. lslet isolation and culture 
Islets were isolated by hand-picking after collagenase digestion of the 
pancreas following a technique previously described [6], In most of the 
experiments, the islets were preincubated overnight at 37°C in a humid- 
ified air incubator with 5% CO.,. The culture medium consisted RPMI 
containing 10% FCS, 2 mM glutamine, 1001U/ml penicillin, 100pg/ml 
streptomycin and 1.8 mM glucose. Other culture conditions had glu- 
cose at physiologic (5.6 raM) or high (11 mM or 22 raM) concentra- 
tions. When insulin was required, the hormone was added to a final 
concentration of 10 -7 M. 
2.5. Tissue extracts 
Following the exposition to the experimental conditions, groups of 
300 islets were either immediately transferred to an Eppendorf tube 
containing 200 pl of buffer A and boiled for 5 rain (when intended for 
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immunoblots of total extracts) or resuspended in l ml of buffer B and 
immediately transferred to ice (when intended for immunoprecipita- 
tions) and homogenized using a polytron PTA 20S homogenize (Brink- 
mann Instruments, Westbury, NY). The extracts were then centrifuged 
at 20,000 x g to remove insoluble material. Determination of protein 
content in the supernatant was performed by the method of Lowry. 
Specimens of liver, muscle and adipose tissue used in immunoblotting 
in parallel to islets extracts were treated as described above for im- 
munoblots except hat the fragment of tissue was homogenized in 1.5 
ml of buffer A. 
2.6. lmmunoprecipitations 
For immunoprecipitations, samples containing 4 mg of total protein 
were incubated with 15/11 of antisera nti-lRS-l, IRS-2 or IR at 4°C 
overnight, followed by the addition of Protein A Sepharose 6 MB for 
1 h. The pellets were repeatedly washed in buffer C (5 × ) and resus- 
pended in 50/~1 of Laemmli sample buffer and boiled for 5 rain prior 
to loading onto the gel [7]. 
2. 7. Protein analysis by immunobhming 
Samples of 150 /2g of total protein were suspended in 50 fll of 
Laemmli sample buffer and boiled for 5 min before loading onto 6% 
SDS-PAGE in a miniature slab gel apparatus. Electrotransfer, blotting 
and the procedures for analysis were as previously described [8 10]. 
3. Results and discussion 
3.1. Constitutive phosphorylation q/'protems in pancreatic Ls'lets 
cultured in low glucose concentration and regulation ~/ 
tyrosine pho,photTlation bv glucose and insulin 
Over the past decade, there has been a dramatic increase in 
the understanding of early postreceptor events in insulin action 
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Fig. 2. Fluorography of an immunoblot of total extracts from rat 
pancreatic slets cultured for 12 h in RPMI containing 1.8 mM glucose 
and pulsed for 90 s with RPMI containing 11 mM glucose or 10 -7 M 
insulin as depicted in the upper margin. Three bands detected upon 
blotting with antiphosphotyrosine a tibody are indicated by the arrows 
in the right-hand margin. Molecular mass standards are depicted in the 
left-hand margin. The results are representative of three experiments 
run in duplicate. 
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Fig. 1. Fluorography of an immunoblot of total extracts from rat 
pancreatic islets cultured for 12 h in RPMI containing 1.8 or 5.6 mM 
glucose as depicted in the upper margin. At least three bands were 
detected upon blotting with antiphosphotyrosine antibody as indicated 
by the arrows in the right-hand margin. Molecular mass standards are 
depicted in the left-hand margin. The results are representative of four 
experiments run in duplicate. 
[1,3]. After insulin binds to the c~ subunit of  its receptor, there 
is an activation of the kinase in the fl subunit, thus, enhancing 
t he tyro sine kinase activity of the receptor towards intracellular 
protein substrates [1,3]. In most cells, this event leads to the 
subsequent tyrosil phosphorylation of two cytoplasm proteins 
with an apparent molecular mass of 165-185 kDa, namely 
1RS-1 and IRS-2. Phosphorylated IRS-1/2 associate and acti- 
vate the lipid metabolizing enzyme PI 3-kinase [1-3]. Thus, IR, 
IRS-1, lRS-2 and PI 3-kinase represent some of the earliest 
steps in insulin action. These initial steps have been well-charac- 
terized in classic insulin target tissues, i.e. liver, muscle and fat 
[11 13]. However, as no information was available regarding 
a possible involvement of this pathway in auto- and paracrine- 
signalling in pancreatic islets, we initially used immunoblotting 
to search for tyrosine-phosphorylated proteins in isolated rat 
pancreatic islets. 
Groups of 300 islets each were cultured for 12 h in RPMI  
containing 1.8 or 5.6 mM glucose. Total islet extracts were 
analysed by immunoblotting using an antiphosphotyrosine an- 
tibody and showed that at least three distinct bands (25 kDa, 
95 kDa and 165-185 kDa) were phosphorylated. Densitometric 
scanning of the bands revealed no differences in phosphoryla- 
tion levels between proteins from islets cultured in media con- 
taining glucose concentrations bellow the threshold for the 
stimulation of  insulin secretion (1.8 raM) and those cultured at 
a physiologic glucose level (5.6 raM) (Fig. 1) (n = 4). Further- 
more, when islets cultured for 12 h in media containing 1.8 mM 
glucose were pulsed for 90 s with media containing 11 mM 
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Fig. 3. Fluorography of immunoblots of IRS-I. IRS-2 or IR im- 
munoprecipitates from rat pancreatic islets cultured for 12 h in RPMI 
containing 1.8 mM glucose and pulsed for 90 s with RPMI containing 
11 mM glucose or 10 -7 M insulin as depicted in the upper margins of 
A and C. In A, the upper part of the nitrocellulose membrane of [RS-I 
and IRS-2 immunoprecipitates was blotted with antiphosphotyrosine 
antibody while, in B, the lower part of the same membrane was blotted 
with anti-p85 PI 3-kinase antibody. In C, the nitrocellulose membrane 
of IR immunoprecipitates was blotted with antiphosphotyrosine anti- 
body and in D the same nitrocellulose membrane was reblotted, after 
stripping, with anti-IR antibody. Molecular mass standards are de- 
picted in the left-hand margin. The results are representative of three 
experiments run in duplicate. 
glucose or 10 .7 M insulin, the tyrosine phosphorylation levels 
of all three bands were increased (Fig. 2) (n = 3). 
3.2. Phosphorylation of lRS-1. IRS-2 and the fl subunit oj the 
IR and association o[ IRS 112 with the p85 subunit of PI 
3-kinase are increased after a pulse qf high glucose or 
exogenous insulin 
As the apparent molecular mass of two of the bands were 
165-185 kDa and 95 kDa, it was suspected that they could 
correspond to IRS-1, IRS-2 and theft subunit of the IR, respec- 
tively. This hypothesis was tested by performing immunopre- 
cipitations with anti- IRS-l,  -IRS-2 or -IR antisera. Groups of 
300 islets cultured for 12 h in media containing 1.8 mM glucose 
were pulsed for 90 s with media containing 11 mM glucose or 
insulin at a final concentration of 10 _7 M. Nitrocellulose mem- 
branes containing the immunoprecipitates were initially blotted 
with antiphosphotyrosine antibody. IRS-I. IRS-2 and IR were 
phosphorylated at the basal condition and underwent an in- 
crease in the tyrosine phosphorylation level after both 11 mM 
355 
glucose or 10 -7 M insulin pulse. The increases in the phospho- 
rylation levels were 2- and 3-fold for IRS-1 after 11 mM glucose 
and 10 -7 M insulin, respectively, 2- and 2.5-fold for IRS-2 after 
11 mM glucose and 10 -7 M insulin, respectively, and 2- and 
2.5-fold for IR after 11 mM glucose and 10 -7 M insulin, respec- 
tively (Fig. 3a,c) (data representative of n = 3). The lower part 
of the membranes from the IRS-I and IRS-2 immunoprecipi- 
tares were blotted with the anti-p85 antibody and the associa- 
tions of IRS-1 and IRS-2 with the regulatory subunit of PI 
3-kinase were detected. The increases in IRS-l-p85 association 
after 11 mM glucose and 10 -7 M insulin pulse were 1.5- and 
2.5-fold, respectively. The increases in IRS-2-p85 association 
after 11 mM glucose and 10 -v M insulin were 1.5- and 2.3-fold, 
respectively (Fig. 3b) (data representative of n = 3). The nitro- 
cellulose membranes of the IR immunoprecipitates were reblot- 
ted using anti-IR antiserum and the amount of IR was similar 
in all three conditions (Fig. 3d) (n = 3). These results provide 
evidence that the tyrosine-phosphorylated band at 165-185 
kDa corresponds to the primary substrates of the IR, IRS-1 
and IRS-2 and that the degree of tyrosine phosphorylation of 
the substrates is responsive to short exposition to insulin or 
high glucose. After longer expositions (60 min or 12 h) to the 
same concentrations of insulin or glucose, the level of tyrosine 
phosphorylation of all bands return to nearly basal (data not 
shown). Shorter exposition to 11 mM glucose does not induce 
an increase in the phosphorylation of the bands while exposi- 
tions as short as 30 s to insulin at 10 -7 M still produce an 
increase in the tyrosine phosphorylation of all three bands (Fig. 
4). Thus, two possible explanations are proposed: (1) Insulin 
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ins 11 1.8 
Fig. 4. Fluorography of immunoblots of IRS-1 immunoprecipitates 
from rat pancreatic slets cultured for 12 h in RPMI containing 1.8 mM 
glucose and pulsed for 30 s with RPMI containing 11 mM glucose or 
10 -v M insulin as depicted in the upper margin. Three bands detected 
upon blotting with antiphosphotyrosine antibody are indicated by the 
arrows in the right-hand margin. Molecular mass standards are de- 
picted in the left-hand margin. The results are representative of two 
experiments run in duplicate. 
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Fig. 5. (A) Fluorography of an immunoblot f total extracts from rat 
adipose tissue, muscle, liver and pancreatic islets as depicted in the 
upper margin. 200/zg of total protein was run in each lane and after 
transfer, the nitrocellulose membranes were blotted with anti-IRS-I 
antibody. The arrow in the right-hand margin indicates the position of 
IRS-I. The results are representative of two experiments run in dupli- 
cate. (B,C) Graphs depicting the relative amounts of IRS-I (B) and IR 
(C) expressed in adipose tissue, muscle, liver and pancreatic slets of the 
rat. The results are representative oftwo experiments run in duplicate. 
treatment leads to IRS phosphorylation and subsequent PI 
3-kinase association while glucose treatment leads to the phos- 
phorylation of IRS at a different site, which does not lead to 
PI 3-kinase association. (2) The effect upon tyrosine phospho- 
rylation after a pulse of high glucose is in fact exerted by an 
autocrine loop of the secreted insulin. 
The identity of the third band (25 kDa) was not determined 
but, as its degree of phosphorylation underwent variations in 
accordance with those of the 165-185 kDa and 95 kDa bands, 
it is suspected that it corresponds to another protein involved 
in the intracellular insulin-signalling pathway, downstream to 
the IR. 
Sorensen and coworkers [4], using inhibitors of tyrosine ki- 
nase, found a 5- to 10-fold increase in insulin secretion in 
isolated neonatal rat pancreatic islets. Moreover, during the 
revision of this paper Rothemberg and coworkers [14] showed 
that an insulin secreting cell line express both IRS-1 and IR and 
that they are rapidly phosphorylated after insulin and IGF 1 
treatment. Finally, Kisanuki and coworkers [15] detected the 
presence of IR in clonal pancreatic ~cells. Recent experiments 
have shown that in tissues that are traditional targets for insulin 
action, PI 3-kinase activation leads to the migration of glucose 
transporters from an intracellular pool to the cell surface, thus, 
regulating the uptake of glucose [16]. PI 3-kinase is also known 
to associate with dynamin and has been implicated in the regu- 
lation of secretory vesicle trafficking [17]. Apparently, via an 
autocrine loop, insulin exerts an inhibitory action upon the 
secretory activity of the/3 cell. Although the intracellular mech- 
anism responsible for this regulation is currently unknown, the 
PI 3-kinase pathway might be involved. Thus, it is possible that 
glucose-induced insulin secretion by the pancreatic fl cell could, 
via an autocrine activation of the IR-signalling pathway, mod- 
ulate negatively the/3 cell's own function. Experiments with 
wortmannin, an inhibitor of PI 3-kinase [18], could be useful 
as a tool for answering this question. 
3.3. Relative amounts of  lRS-1 and IR in pancreatic islets in 
comparison to tissues that are traditional targets for insulin 
action 
200/lg of total protein from freshly prepared homogenates 
of liver, fat and muscle were separated by SDS-PAGE in paral- 
lel to the same amount of proteins from rat pancreatic islets 
cultured for 12 h in RPMI containing 1.8 mM glucose. Nitro- 
cellulose membranes from the electrotransfers were blotted 
with antisera nti-IRS-1 and -IR. Quantitation by densitomet- 
tic scanning of the specific bands revealed that the IRS-1 was 
present in liver, muscle, fat and islets in the following propor- 
tions based on arbitrary densitometric units: 100, 85, 78 and 18. 
For the IR, the relation was 100, 92, 85 and 16, respectively, 
for liver, muscle, fat and pancreatic islets (n = 2) (Fig. 5). 
In summary, isolated rat pancreatic islets possess proteins 
that are phosphorylated at tyrosine residues. The level of phos- 
phorylation is regulated by glucose and insulin although the 
effects of glucose occurs possibly through its insulin secretory 
activity. Three of these proteins were identified as components 
of the insulin-signalling pathway and may be involved in auto- 
and paracrine regulation in the islets of Langerhans. 
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